Global and Region Nasal Drug Delivery Technology Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The report details the trend, potential and market size of Nasal Drug Delivery Technology market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Nasal Drug Delivery Technologymarket, defines the market attractiveness level of Nasal Drug Delivery Technology market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Nasal Drug Delivery Technology industry, describes the types of Nasal Drug Delivery Technology market, the applications of major players and the market size, and deeply analyzes the current situation of the global Nasal Drug Delivery Technology market and the development prospects and opportunities of Nasal Drug Delivery Technology industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Nasal Drug Delivery Technology market in Chapter 13.

    By Player:

    • Aegis Therapeutics LLC

    • Merck & Co, Inc

    • ENT Technologies Pty Ltd

    • Shin Nippon Biomedical Laboratories

    • Dickinson and Company

    • Pfizer, Inc

    • PendoPharm, Inc

    • OptiNose, Inc

    • Becton, Dickinson and Company

    • BF Ascher & Company, Inc

    • Novartis AG

    • Douglas Pharmaceuticals Ltd

    • Glaxosmithkline PLC

    • Promius Pharma, LLC

    • 3M United States

    • Cadila Pharmaceuticals Ltd

    • Johnson & Johnson

    • Aptargroup, Inc

    By Type:

    • Pressurized Type

    • Non-pressurized Type

    By End-User:

    • Nasal Congestion

    • Rhinitis

    • Asthma

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Nasal Drug Delivery Technology Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Nasal Drug Delivery Technology Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Nasal Drug Delivery Technology Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Nasal Drug Delivery Technology Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Nasal Drug Delivery Technology Market Analysis and Outlook to 2022

    • 7.1 Global Nasal Drug Delivery Technology Consumption (2017-2022)

    • 7.2 United States Nasal Drug Delivery Technology Consumption (2017-2022)

    • 7.3 Europe Nasal Drug Delivery Technology Consumption (2017-2022)

    • 7.4 China Nasal Drug Delivery Technology Consumption (2017-2022)

    • 7.5 Japan Nasal Drug Delivery Technology Consumption (2017-2022)

    • 7.6 India Nasal Drug Delivery Technology Consumption (2017-2022)

    • 7.7 South Korea Nasal Drug Delivery Technology Consumption (2017-2022)

    8 Region and Country-wise Nasal Drug Delivery Technology Market Analysis and Outlook to 2028

    • 8.1 Global Nasal Drug Delivery Technology Consumption Forecast (2022-2028)

    • 8.2 United States Nasal Drug Delivery Technology Consumption Forecast (2022-2028)

    • 8.3 Europe Nasal Drug Delivery Technology Consumption Forecast (2022-2028)

    • 8.4 China Nasal Drug Delivery Technology Consumption Forecast (2022-2028)

    • 8.5 Japan Nasal Drug Delivery Technology Consumption Forecast (2022-2028)

    • 8.6 India Nasal Drug Delivery Technology Consumption Forecast (2022-2028)

    • 8.7 South Korea Nasal Drug Delivery Technology Consumption Forecast (2022-2028)

    9 Global Nasal Drug Delivery Technology Market Outlook by Types and Applications to 2022

    • 9.1 Global Nasal Drug Delivery Technology Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Pressurized Type Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Non-pressurized Type Consumption and Growth Rate (2017-2022)

    • 9.2 Global Nasal Drug Delivery Technology Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Nasal Congestion Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Rhinitis Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Asthma Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Nasal Drug Delivery Technology Market Outlook by Types and Applications to 2028

    • 10.1 Global Nasal Drug Delivery Technology Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Pressurized Type Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Non-pressurized Type Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Nasal Drug Delivery Technology Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Nasal Congestion Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Rhinitis Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Asthma Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Nasal Drug Delivery Technology Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Nasal Drug Delivery Technology Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Nasal Drug Delivery Technology Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Nasal Drug Delivery Technology Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Nasal Drug Delivery Technology Market Competitive Analysis

    • 14.1 Aegis Therapeutics LLC

      • 14.1.1 Aegis Therapeutics LLC Company Details

      • 14.1.2 Aegis Therapeutics LLC Nasal Drug Delivery Technology Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Aegis Therapeutics LLC Nasal Drug Delivery Technology Product and Service

    • 14.2 Merck & Co, Inc

      • 14.2.1 Merck & Co, Inc Company Details

      • 14.2.2 Merck & Co, Inc Nasal Drug Delivery Technology Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Merck & Co, Inc Nasal Drug Delivery Technology Product and Service

    • 14.3 ENT Technologies Pty Ltd

      • 14.3.1 ENT Technologies Pty Ltd Company Details

      • 14.3.2 ENT Technologies Pty Ltd Nasal Drug Delivery Technology Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 ENT Technologies Pty Ltd Nasal Drug Delivery Technology Product and Service

    • 14.4 Shin Nippon Biomedical Laboratories

      • 14.4.1 Shin Nippon Biomedical Laboratories Company Details

      • 14.4.2 Shin Nippon Biomedical Laboratories Nasal Drug Delivery Technology Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Shin Nippon Biomedical Laboratories Nasal Drug Delivery Technology Product and Service

    • 14.5 Dickinson and Company

      • 14.5.1 Dickinson and Company Company Details

      • 14.5.2 Dickinson and Company Nasal Drug Delivery Technology Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Dickinson and Company Nasal Drug Delivery Technology Product and Service

    • 14.6 Pfizer, Inc

      • 14.6.1 Pfizer, Inc Company Details

      • 14.6.2 Pfizer, Inc Nasal Drug Delivery Technology Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Pfizer, Inc Nasal Drug Delivery Technology Product and Service

    • 14.7 PendoPharm, Inc

      • 14.7.1 PendoPharm, Inc Company Details

      • 14.7.2 PendoPharm, Inc Nasal Drug Delivery Technology Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 PendoPharm, Inc Nasal Drug Delivery Technology Product and Service

    • 14.8 OptiNose, Inc

      • 14.8.1 OptiNose, Inc Company Details

      • 14.8.2 OptiNose, Inc Nasal Drug Delivery Technology Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 OptiNose, Inc Nasal Drug Delivery Technology Product and Service

    • 14.9 Becton, Dickinson and Company

      • 14.9.1 Becton, Dickinson and Company Company Details

      • 14.9.2 Becton, Dickinson and Company Nasal Drug Delivery Technology Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Becton, Dickinson and Company Nasal Drug Delivery Technology Product and Service

    • 14.10 BF Ascher & Company, Inc

      • 14.10.1 BF Ascher & Company, Inc Company Details

      • 14.10.2 BF Ascher & Company, Inc Nasal Drug Delivery Technology Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 BF Ascher & Company, Inc Nasal Drug Delivery Technology Product and Service

    • 14.11 Novartis AG

      • 14.11.1 Novartis AG Company Details

      • 14.11.2 Novartis AG Nasal Drug Delivery Technology Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Novartis AG Nasal Drug Delivery Technology Product and Service

    • 14.12 Douglas Pharmaceuticals Ltd

      • 14.12.1 Douglas Pharmaceuticals Ltd Company Details

      • 14.12.2 Douglas Pharmaceuticals Ltd Nasal Drug Delivery Technology Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Douglas Pharmaceuticals Ltd Nasal Drug Delivery Technology Product and Service

    • 14.13 Glaxosmithkline PLC

      • 14.13.1 Glaxosmithkline PLC Company Details

      • 14.13.2 Glaxosmithkline PLC Nasal Drug Delivery Technology Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Glaxosmithkline PLC Nasal Drug Delivery Technology Product and Service

    • 14.14 Promius Pharma, LLC

      • 14.14.1 Promius Pharma, LLC Company Details

      • 14.14.2 Promius Pharma, LLC Nasal Drug Delivery Technology Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Promius Pharma, LLC Nasal Drug Delivery Technology Product and Service

    • 14.15 3M United States

      • 14.15.1 3M United States Company Details

      • 14.15.2 3M United States Nasal Drug Delivery Technology Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 3M United States Nasal Drug Delivery Technology Product and Service

    • 14.16 Cadila Pharmaceuticals Ltd

      • 14.16.1 Cadila Pharmaceuticals Ltd Company Details

      • 14.16.2 Cadila Pharmaceuticals Ltd Nasal Drug Delivery Technology Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Cadila Pharmaceuticals Ltd Nasal Drug Delivery Technology Product and Service

    • 14.17 Johnson & Johnson

      • 14.17.1 Johnson & Johnson Company Details

      • 14.17.2 Johnson & Johnson Nasal Drug Delivery Technology Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Johnson & Johnson Nasal Drug Delivery Technology Product and Service

    • 14.18 Aptargroup, Inc

      • 14.18.1 Aptargroup, Inc Company Details

      • 14.18.2 Aptargroup, Inc Nasal Drug Delivery Technology Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Aptargroup, Inc Nasal Drug Delivery Technology Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Nasal Drug Delivery Technology

    • Figure Nasal Drug Delivery Technology Picture

    • Table Global Nasal Drug Delivery Technology Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Nasal Drug Delivery Technology Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Nasal Drug Delivery Technology Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Nasal Drug Delivery Technology Consumption by Country (2017-2022)

    • Figure United States Nasal Drug Delivery Technology Consumption and Growth Rate (2017-2022)

    • Table Europe Nasal Drug Delivery Technology Consumption and Growth Rate (2017-2022)

    • Figure China Nasal Drug Delivery Technology Consumption and Growth Rate (2017-2022)

    • Figure Japan Nasal Drug Delivery Technology Consumption and Growth Rate (2017-2022)

    • Figure India Nasal Drug Delivery Technology Consumption and Growth Rate (2017-2022)

    • Figure South Korea Nasal Drug Delivery Technology Consumption and Growth Rate (2017-2022)

    • Figure Global Nasal Drug Delivery Technology Consumption Forecast by Country (2022-2028)

    • Figure United States Nasal Drug Delivery Technology Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Nasal Drug Delivery Technology Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Nasal Drug Delivery Technology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Nasal Drug Delivery Technology Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Nasal Drug Delivery Technology Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Nasal Drug Delivery Technology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pressurized Type Consumption and Growth Rate (2017-2022)

    • Figure Global Non-pressurized Type Consumption and Growth Rate (2017-2022)

    • Figure Global Nasal Congestion Consumption and Growth Rate (2017-2022)

    • Figure Global Rhinitis Consumption and Growth Rate (2017-2022)

    • Figure Global Asthma Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Pressurized Type Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Non-pressurized Type Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Nasal Congestion Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Rhinitis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Asthma Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Nasal Drug Delivery Technology Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Nasal Drug Delivery Technology Export by Region (Top 5 Countries) (2017-2028)

    • Table Aegis Therapeutics LLC (Foundation Year, Company Profile and etc.)

    • Table Aegis Therapeutics LLC Nasal Drug Delivery Technology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aegis Therapeutics LLC Nasal Drug Delivery Technology Product and Service

    • Table Merck & Co, Inc (Foundation Year, Company Profile and etc.)

    • Table Merck & Co, Inc Nasal Drug Delivery Technology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co, Inc Nasal Drug Delivery Technology Product and Service

    • Table ENT Technologies Pty Ltd (Foundation Year, Company Profile and etc.)

    • Table ENT Technologies Pty Ltd Nasal Drug Delivery Technology Sales, Price, Value and Gross Profit (2017-2022)

    • Table ENT Technologies Pty Ltd Nasal Drug Delivery Technology Product and Service

    • Table Shin Nippon Biomedical Laboratories (Foundation Year, Company Profile and etc.)

    • Table Shin Nippon Biomedical Laboratories Nasal Drug Delivery Technology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shin Nippon Biomedical Laboratories Nasal Drug Delivery Technology Product and Service

    • Table Dickinson and Company (Foundation Year, Company Profile and etc.)

    • Table Dickinson and Company Nasal Drug Delivery Technology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dickinson and Company Nasal Drug Delivery Technology Product and Service

    • Table Pfizer, Inc (Foundation Year, Company Profile and etc.)

    • Table Pfizer, Inc Nasal Drug Delivery Technology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer, Inc Nasal Drug Delivery Technology Product and Service

    • Table PendoPharm, Inc (Foundation Year, Company Profile and etc.)

    • Table PendoPharm, Inc Nasal Drug Delivery Technology Sales, Price, Value and Gross Profit (2017-2022)

    • Table PendoPharm, Inc Nasal Drug Delivery Technology Product and Service

    • Table OptiNose, Inc (Foundation Year, Company Profile and etc.)

    • Table OptiNose, Inc Nasal Drug Delivery Technology Sales, Price, Value and Gross Profit (2017-2022)

    • Table OptiNose, Inc Nasal Drug Delivery Technology Product and Service

    • Table Becton, Dickinson and Company (Foundation Year, Company Profile and etc.)

    • Table Becton, Dickinson and Company Nasal Drug Delivery Technology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Becton, Dickinson and Company Nasal Drug Delivery Technology Product and Service

    • Table BF Ascher & Company, Inc (Foundation Year, Company Profile and etc.)

    • Table BF Ascher & Company, Inc Nasal Drug Delivery Technology Sales, Price, Value and Gross Profit (2017-2022)

    • Table BF Ascher & Company, Inc Nasal Drug Delivery Technology Product and Service

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG Nasal Drug Delivery Technology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Nasal Drug Delivery Technology Product and Service

    • Table Douglas Pharmaceuticals Ltd (Foundation Year, Company Profile and etc.)

    • Table Douglas Pharmaceuticals Ltd Nasal Drug Delivery Technology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Douglas Pharmaceuticals Ltd Nasal Drug Delivery Technology Product and Service

    • Table Glaxosmithkline PLC (Foundation Year, Company Profile and etc.)

    • Table Glaxosmithkline PLC Nasal Drug Delivery Technology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Glaxosmithkline PLC Nasal Drug Delivery Technology Product and Service

    • Table Promius Pharma, LLC (Foundation Year, Company Profile and etc.)

    • Table Promius Pharma, LLC Nasal Drug Delivery Technology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Promius Pharma, LLC Nasal Drug Delivery Technology Product and Service

    • Table 3M United States (Foundation Year, Company Profile and etc.)

    • Table 3M United States Nasal Drug Delivery Technology Sales, Price, Value and Gross Profit (2017-2022)

    • Table 3M United States Nasal Drug Delivery Technology Product and Service

    • Table Cadila Pharmaceuticals Ltd (Foundation Year, Company Profile and etc.)

    • Table Cadila Pharmaceuticals Ltd Nasal Drug Delivery Technology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cadila Pharmaceuticals Ltd Nasal Drug Delivery Technology Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Nasal Drug Delivery Technology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Nasal Drug Delivery Technology Product and Service

    • Table Aptargroup, Inc (Foundation Year, Company Profile and etc.)

    • Table Aptargroup, Inc Nasal Drug Delivery Technology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aptargroup, Inc Nasal Drug Delivery Technology Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.